人工血管市場：製品タイプ、血管径、適応症、エンドユーザー、流通チャネル別-2025-2030年世界予測

人工血管市場は、2024年には23億米ドルとなり、2025年には24億7,000万米ドル、CAGR 7.39%で成長し、2030年には35億3,000万米ドルに達すると予測されています。

人工血管市場は、技術の進歩、低侵襲手技の需要増、精密医療への注目の高まりに牽引され、過去10年間で大きく発展してきました。今日の臨床環境では、患者もヘルスケア・システムも同様に、血管の状態を管理するための耐久性と生体適合性に優れたソリューションを求めています。このダイナミックな分野は、革新的な製品開発と患者の転帰を向上させるという強いコミットメントによって特徴付けられています。メーカー各社は、性能の向上、合併症の軽減、および高度な手術手技とのシームレスな統合を実現するために、移植片の設計を改良してきました。臨床的エビデンスの積み重ねは、生物学的および合成的な選択肢の活用を支持しており、患者固有の要因や外科的要件に応じて、それぞれが独自の利点を提供しています。一方、規制の枠組みは技術革新に対応して更新され続けており、確固とした臨床試験と市販後調査の重要な必要性が強調されています。市場の競争が激化する中、利害関係者はアンメットニーズに的確に対応するための研究開発に投資しています。このイントロダクションでは、市場のセグメンテーション、地域ダイナミックス、競合情勢、そしてこの変革期を乗り切るための業界リーダーの指針となる戦略的提言について詳細に分析します。この後の叙述では、これらのテーマに基づき、新たな動向、重要な成長促進要因、次世代技術革新が人工血管市場に与える影響に焦点を当てます。

人工血管市場の変革

新たな技術と臨床革新が従来のやり方を再定義する中、人工血管業界の情勢はパラダイム・シフトを迎えています。近年、従来の外科的アプローチから、より洗練された低侵襲手技への移行が顕著になり、より早い回復と術後合併症の減少が可能になりました。先進的な移植片材料とデザインの改良により、移植器具の寿命と機能的統合が大幅に向上しました。新しい生体工学技術により、耐久性だけでなく、天然組織を忠実に模倣した移植片を作製する道が開かれ、生体適合性と治癒成績が向上しています。規制機関もガイドラインを改訂してこうした技術革新に対応し、新規治療が高い安全性と有効性の基準を満たすようにしています。この進化する環境は、伝統的なメーカーがハイテク・イノベーターと協力して新たな市場セグメントを獲得する戦略的再編成につながりました。デジタルヘルス・ソリューションと精密医療の融合もまた、移植片の性能を最適化する包括的なモニタリングとオーダーメイドの治療計画を提供し、ますます重要な役割を果たしています。利害関係者は今や、市場の変化を予測し、それに応じて投資戦略を調整する能力を備えています。このシフトは、製品開拓と市販後調査の両方におけるデータ分析と人工知能の統合によってさらに強調され、より患者中心で技術主導の未来に向けた業界の進化を確固たるものにしています。

人工血管市場の主要セグメンテーション洞察

市場セグメンテーションの詳細な分析により、患者のニーズ、製品の革新性、地域の需要について微妙な理解が得られます。製品タイプの検査では、市場は慎重に生物学的人工血管と合成人工血管に分けられます。生物学的移植片は、同種移植片、自家移植片、異種移植片の微妙な違いによってさらに研究され、それぞれが明確な臨床的特徴や患者適合性を有しています。同時に、合成人工血管は、ポリエステル、ポリテトラフルオロエチレン、ポリウレタンなどの材料構成に焦点を当てて分析され、さまざまな性能指標とコスト構造に光を当てています。製品タイプだけでなく、血管径によるセグメンテーションでは、大血管と小血管に基づいてグラフトを分類することで、さらに複雑なレイヤーを導入しています。分析は適応症にも及び、一般的な手術には大動脈バイパス手術、脳動脈バイパス手術、冠動脈バイパス手術、下肢バイパス手術、末梢動脈バイパス手術、腎動脈バイパス手術が含まれます。さらに、外来手術センターと病院＆クリニックの両方を網羅するエンドユーザーを調査することで、より詳細な情報を提供する一方、販売チャネルはオフラインとオンラインの様式で評価します。このような詳細なセグメンテーションは、競争の激しいヘルスケア業界における戦略的計画と市場ポジショニングに不可欠な、実用的な考察を提供します。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心血管疾患の罹患率の増加により、人工血管ソリューションの必要性が高まっています。
    • 政府の支援的な規制と有利な償還政策が、汚職申請を促進する
  • 抑制要因
    • 人工血管に関連する製品リコールおよび有害事象に関する懸念
  • 機会
    • ACSインフラの拡大と非侵襲的手術の優先
    • 血管内手術用のカスタムおよびバイオベースの血管移植片への重点的な取り組み
  • 課題
    • 複数地域の規制環境と厳格な臨床エンドポイントの達成に関連する問題
• 市場セグメンテーション分析
  • 製品タイプ：治療における生物学的適合性による同種移植の大きな利点
  • 血管径：高流量血管の血流回復のための大口径人工血管の使用拡大
  • エンドユーザー：手術時間の短縮を目的とした外来手術センターでの血管移植の適用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 人工血管市場：製品タイプ別

• 生物学的血管移植
  • 同種移植
  • 自家移植
  • 異種移植
• 合成血管移植
  • ポリエステル
  • ポリテトラフルオロエチレン
  • ポリウレタン

第7章 人工血管市場血管径別

• 大きい
• 小さい

第8章 人工血管市場：適応症別

• 大動脈腸骨バイパス手術
• 脳動脈バイパス手術
• 冠動脈バイパス手術
• 下肢バイパス手術
• 末梢動脈バイパス手術
• 腎動脈バイパス手術

第9章 人工血管市場：エンドユーザー別

• 外来手術センター
• 病院と診療所

第10章 人工血管市場：流通チャネル別

• オフライン
• オンライン

第11章 南北アメリカの人工血管市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の人工血管市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの人工血管市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Affluent Medical
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• BIOVIC Sdn. Bhd.
• Boston Scientific Corporation
• Cardinal Health Inc.
• Cook Medical, Inc.
• Corcym S.r.l.
• CryoLife, Inc.
• Endologix Inc.
• Getinge AB
• Heart Medical Europe B.V.
• Japan Lifeline Co., Ltd.
• Lemaitre Vascular, Inc.
• Medtronic PLC
• Merit Medical Systems, Inc.
• Perouse Medical SAS by Vygon SAS
• Rua Life Sciences PLC
• Shanghai Suokang Medical Implants Co. Ltd.
• Terumo Corporation
• Vascular Graft Solutions Ltd.
• VUP Medical
• W. L. Gore & Associates, Inc.
• Xeltis B.V.

LIST OF FIGURES

• FIGURE 1. VASCULAR GRAFT MARKET MULTI-CURRENCY
• FIGURE 2. VASCULAR GRAFT MARKET MULTI-LANGUAGE
• FIGURE 3. VASCULAR GRAFT MARKET RESEARCH PROCESS
• FIGURE 4. VASCULAR GRAFT MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. VASCULAR GRAFT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VASCULAR GRAFT MARKET DYNAMICS
• TABLE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AUTOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY XENOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LARGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VASCULAR GRAFT MARKET SIZE, BY SMALL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AORTOILIAC BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CEREBRAL ARTERY BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL VASCULAR GRAFT MARKET SIZE, BY LOWER EXTREMITY BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL ARTERY BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RENAL ARTERY BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL VASCULAR GRAFT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. CANADA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. CANADA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 58. CANADA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 59. CANADA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 60. CANADA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. CANADA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. CANADA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. CHINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. CHINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 95. CHINA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 96. CHINA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 97. CHINA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. CHINA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. CHINA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. INDIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. INDIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 102. INDIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 103. INDIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 104. INDIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 105. INDIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. INDIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 107. INDONESIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 114. JAPAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 135. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 142. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 149. TAIWAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 156. THAILAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 163. VIETNAM VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 178. DENMARK VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 185. EGYPT VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 192. FINLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 199. FRANCE VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 206. GERMANY VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 213. ISRAEL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 220. ITALY VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 221. ITALY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 222. ITALY VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 223. ITALY VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 224. ITALY VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 225. ITALY VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 226. ITALY VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 227. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 234. NIGERIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 241. NORWAY VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 248. POLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 249. POLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 250. POLAND VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 251. POLAND VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 252. POLAND VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 253. POLAND VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 254. POLAND VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 255. QATAR VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 256. QATAR VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 257. QATAR VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 258. QATAR VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 259. QATAR VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 260. QATAR VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 261. QATAR VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 262. RUSSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 269. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 276. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 283. SPAIN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 284. SPAIN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 290. SWEDEN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 291. SWEDEN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 297. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 298. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 304. TURKEY VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 305. TURKEY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 311. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 312. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 313. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 318. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 319. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 320. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2030 (USD MILLION)
• TABLE 321. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2030 (USD MILLION)
• TABLE 322. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 323. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 324. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 325. VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 326. VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, 2024

The Vascular Graft Market was valued at USD 2.30 billion in 2024 and is projected to grow to USD 2.47 billion in 2025, with a CAGR of 7.39%, reaching USD 3.53 billion by 2030.

The vascular graft market has evolved significantly over the past decade, driven by technological advancements, increasing demand for minimally invasive procedures, and a growing focus on precision medicine. In today's clinical environment, patients and healthcare systems alike are searching for durable and biocompatible solutions to manage vascular conditions. This dynamic field is characterized by innovative product developments and a strong commitment to enhancing patient outcomes. Manufacturers have refined graft designs to improve performance, reduce complications, and integrate seamlessly with advanced surgical techniques. The growing body of clinical evidence supports the utilization of both biological and synthetic options, each offering unique advantages depending on patient-specific factors and surgical requirements. Meanwhile, regulatory frameworks continue to be updated in response to technological innovations, emphasizing the critical need for robust clinical studies and post-market surveillance. As the market becomes increasingly competitive, stakeholders are investing in research and development to address unmet needs with greater precision. This introduction sets the stage for an in-depth analysis of market segmentation, regional dynamics, competitive landscapes, and strategic recommendations that can guide industry leaders in navigating these transformative times. The narrative that follows builds on these themes, highlighting emerging trends, critical growth drivers, and the impact of next-generation innovations on the vascular graft market.

Transformative Shifts in the Vascular Graft Market Landscape

The landscape of the vascular graft industry is undergoing a paradigm shift as emerging technologies and clinical innovations redefine traditional practices. Recent years have witnessed a marked move from conventional surgical approaches to more sophisticated minimally invasive procedures, enabling faster recovery and reducing post-operative complications. Advanced graft materials and design improvements have greatly enhanced the life span and functional integration of implanted devices. New bioengineering techniques have opened up avenues to create grafts that are not only durable but also closely mimic natural tissue, thereby improving biocompatibility and healing outcomes. Regulatory bodies are adapting to these innovations with revised guidelines, ensuring that novel therapies meet high safety and efficacy standards. This evolving environment has led to strategic realignments where traditional manufacturers collaborate with high-tech innovators to capture new market segments. The convergence of digital health solutions and precision medicine is also playing an increasingly important role, offering comprehensive monitoring and tailored treatment plans that optimize graft performance. Stakeholders are now better equipped to anticipate market shifts and align their investment strategies accordingly. This shift is further underscored by the integration of data analytics and artificial intelligence in both product development and post-market surveillance, solidifying the industry's evolution towards a more patient-centric and technologically-driven future.

Key Segmentation Insights in Vascular Graft Markets

The detailed analysis of market segmentation offers a nuanced understanding of patient needs, product innovation, and regional demand. In inspecting the product type, the market is carefully divided into biological and synthetic vascular grafts. Biological grafts are studied further by the subtle differences among allografts, autografts, and xenografts, each possessing distinct clinical features and patient compatibility attributes. Simultaneously, synthetic vascular grafts are analyzed with a focus on material composition such as polyester, polytetrafluoroethylene, and polyurethane, shedding light on varied performance metrics and cost structures. Beyond product type, segmentation by blood vessel diameter introduces an additional layer of complexity by categorizing grafts based on large and small vessels, which informs both surgical decision-making and device customization. The analysis extends to indications, noting that common procedures include aortoiliac bypass surgery, cerebral artery bypass surgery, coronary artery bypass surgery, lower extremity bypass surgery, peripheral artery bypass surgery, and renal artery bypass surgery. Further granularity is provided by examining the end users which encompass both ambulatory surgical centers and hospitals & clinics, while distribution channels are evaluated across offline and online modalities. Such an in-depth segmentation provides actionable insights that are crucial for strategic planning and market positioning in a competitive healthcare industry.

Based on Product Type, market is studied across Biological Vascular Grafts and Synthetic Vascular Grafts. The Biological Vascular Grafts is further studied across Allografts, Autografts, and Xenografts. The Synthetic Vascular Grafts is further studied across Polyester, Polytetrafluoroethylene, and Polyurethane.

Based on Blood Vessel Diameter, market is studied across Large and Small.

Based on Indication, market is studied across Aortoiliac Bypass Surgery, Cerebral Artery Bypass Surgery, Coronary Artery Bypass Surgery, Lower Extremity Bypass Surgery, Peripheral Artery Bypass Surgery, and Renal Artery Bypass Surgery.

Based on End User, market is studied across Ambulatory Surgical Centers and Hospitals & Clinics.

Based on Distribution Channel, market is studied across Offline and Online.

Key Regional Insights Impacting the Vascular Graft Demand

The global distribution of the vascular graft market reveals distinct regional dynamics that are instrumental in shaping market strategies. In the Americas, a mature healthcare infrastructure combined with high adoption rates of advanced medical devices propels significant demand. There is consistent growth fueled by innovations in product technology and robust reimbursement policies that foster a favorable market environment. In the Europe, Middle East & Africa region, evolving demographic trends and increased healthcare spending drive market expansion. Here, regulatory reforms and strategic collaborations between local and multinational players have opened new avenues for clinical applications, thus broadening the market potential. Meanwhile, the Asia-Pacific region is emerging as a fast-growing frontier in this arena, bolstered by rapid economic growth, expanding healthcare access, and a rising prevalence of vascular diseases. Investments in state-of-the-art facilities and the acceleration of medical tourism further contribute to regional vibrancy. Each region, with its distinctive healthcare challenges and opportunities, underscores the importance of tailored marketing strategies and localized innovation to capture the nuanced demands of diverse patient populations while aligning with regional regulatory and economic conditions.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the Vascular Graft Market

Within the competitive ecosystem of the vascular graft market, several market leaders have distinguished themselves through continuous innovation, exceptional product quality, and expansive global reach. Notable industry players such as Abbott Laboratories, Affluent Medical, B. Braun Melsungen AG, Becton, Dickinson and Company, and BIOVIC Sdn. Bhd. have been instrumental in driving technological advancements and setting benchmarks for clinical efficacy. Other influential companies, including Boston Scientific Corporation, Cardinal Health Inc., Cook Medical, Inc., Corcym S.r.l., and CryoLife, Inc., have significantly contributed to expanding the portfolio of vascular graft offerings, focusing on both biological and synthetic solutions. Firms like Endologix Inc., Getinge AB, and Heart Medical Europe B.V. further enhance market competitiveness through strategic product innovations and aggressive R&D investments. Esteemed organizations such as Japan Lifeline Co., Ltd., Lemaitre Vascular, Inc., Medtronic PLC, Merit Medical Systems, Inc., and Perouse Medical SAS by Vygon SAS continue to innovate in device design and surgical compatibility. Additionally, Rua Life Sciences PLC, Shanghai Suokang Medical Implants Co. Ltd., Terumo Corporation, Vascular Graft Solutions Ltd., VUP Medical, W. L. Gore & Associates, Inc., and Xeltis B.V. play pivotal roles in pushing the boundaries of what is clinically achievable. Their combined efforts not only enhance patient care but also redefine the competitive dynamics of the vascular graft sector.

The report delves into recent significant developments in the Vascular Graft Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Affluent Medical, B. Braun Melsungen AG, Becton, Dickinson and Company, BIOVIC Sdn. Bhd., Boston Scientific Corporation, Cardinal Health Inc., Cook Medical, Inc., Corcym S.r.l., CryoLife, Inc., Endologix Inc., Getinge AB, Heart Medical Europe B.V., Japan Lifeline Co., Ltd., Lemaitre Vascular, Inc., Medtronic PLC, Merit Medical Systems, Inc., Perouse Medical SAS by Vygon SAS, Rua Life Sciences PLC, Shanghai Suokang Medical Implants Co. Ltd., Terumo Corporation, Vascular Graft Solutions Ltd., VUP Medical, W. L. Gore & Associates, Inc., and Xeltis B.V.. Actionable Recommendations for Industry Leaders in Vascular Grafts

For industry leaders seeking to capture the opportunities present in the dynamic vascular graft market, a multifaceted strategy is essential. First, investing in advanced research and development is crucial to harness innovations that improve graft biocompatibility and longevity. Collaborations with research institutions and leveraging data analytics can accelerate the development of next-generation products. Next, companies should focus on strategic partnerships that enhance regional market penetration while also expanding global footprints. An emphasis on tailoring products to meet the specific needs of diverse patient segments, whether based on product type, vessel diameter, or procedural indication, will prove beneficial. Additionally, companies are encouraged to adopt a robust digital transformation strategy by optimizing both online and offline distribution channels to ensure broader market access and increased consumer engagement. Proactive engagement with regulatory bodies to streamline approval processes is also recommended, ensuring that new innovations can be brought to market swiftly and safely. By aligning these strategies with a deep understanding of regional dynamics and competitive landscapes, industry leaders can sustainably drive growth, enhance clinical outcomes, and maintain a competitive edge in this rapidly evolving market.

Conclusion on the Future of Vascular Grafts

In summary, the vascular graft market is characterized by both significant challenges and substantial opportunities propelled by continuous medical innovations and evolving patient needs. The integration of advanced materials, innovative design approaches, and strategic segmentation has redefined how vascular conditions are managed globally. Key regional differences and robust competitive dynamics further underscore the importance of a tailored, agile approach to market strategy. Looking forward, companies that invest in research, engage in strategic partnerships, and adapt quickly to regulatory shifts are best positioned to lead the industry into the next phase of development. This evolving market promises not only improved patient outcomes through state-of-the-art graft solutions but also sustainable growth trajectories for forward-thinking organizations. As stakeholder focus intensifies on precision and customization, the path ahead is one of both dynamic change and steadfast opportunity.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of cardiovascular diseases enhance the need for vascular graft solutions
    • 5.1.1.2. Supportive government regulations and favorable reimbursement policies enhancing graft applications
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns associated with product recall and adverse findings related to vascular graft
  • 5.1.3. Opportunities
    • 5.1.3.1. Expanding ACS infrastructure and preferences for non-invasive surgeries
    • 5.1.3.2. Heightened focus on custom and biobased vascular grafts for endovascular surgeries
  • 5.1.4. Challenges
    • 5.1.4.1. Issues related to multi-regional regulatory landscapes and meeting rigorous clinical endpoints
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Significant benefits of allografts owing to biological compatibility in treatment
  • 5.2.2. Blood Vessel Diameter: Expanding usage of large-diameter artificial blood vessels for restoring blood flow in high-flow vessels
  • 5.2.3. End User: Growing applications of vascular grafts in ambulatory surgical centers for reduced operative time
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Vascular Graft Market, by Product Type

• 6.1. Introduction
• 6.2. Biological Vascular Grafts
  • 6.2.1. Allografts
  • 6.2.2. Autografts
  • 6.2.3. Xenografts
• 6.3. Synthetic Vascular Grafts
  • 6.3.1. Polyester
  • 6.3.2. Polytetrafluoroethylene
  • 6.3.3. Polyurethane

7. Vascular Graft Market, by Blood Vessel Diameter

• 7.1. Introduction
• 7.2. Large
• 7.3. Small

8. Vascular Graft Market, by Indication

• 8.1. Introduction
• 8.2. Aortoiliac Bypass Surgery
• 8.3. Cerebral Artery Bypass Surgery
• 8.4. Coronary Artery Bypass Surgery
• 8.5. Lower Extremity Bypass Surgery
• 8.6. Peripheral Artery Bypass Surgery
• 8.7. Renal Artery Bypass Surgery

9. Vascular Graft Market, by End User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Hospitals & Clinics

10. Vascular Graft Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Offline
• 10.3. Online

11. Americas Vascular Graft Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Vascular Graft Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Vascular Graft Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Bentley enhances vascular offerings with expanded FEVAR indication for BeGraft and the launch of BeFlared bridging stent
  • 14.3.2. Terumo India unveils innovative Treo Abdominal Stent Graft System
  • 14.3.3. PexaLabs' EXGraft vascular grafts gain expanded CE mark
  • 14.3.4. Aquedeon Medical, Inc. Receives FDA IDE Approval for the Duett Vascular Graft System
  • 14.3.5. Xeltis' aXess Vascular Graft Development Receives Funding From European Innovation Council
  • 14.3.6. Vygon Partners with Carmat to Develop a Vascular Graft for an Artificial Heart
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Affluent Medical
• 3. B. Braun Melsungen AG
• 4. Becton, Dickinson and Company
• 5. BIOVIC Sdn. Bhd.
• 6. Boston Scientific Corporation
• 7. Cardinal Health Inc.
• 8. Cook Medical, Inc.
• 9. Corcym S.r.l.
• 10. CryoLife, Inc.
• 11. Endologix Inc.
• 12. Getinge AB
• 13. Heart Medical Europe B.V.
• 14. Japan Lifeline Co., Ltd.
• 15. Lemaitre Vascular, Inc.
• 16. Medtronic PLC
• 17. Merit Medical Systems, Inc.
• 18. Perouse Medical SAS by Vygon SAS
• 19. Rua Life Sciences PLC
• 20. Shanghai Suokang Medical Implants Co. Ltd.
• 21. Terumo Corporation
• 22. Vascular Graft Solutions Ltd.
• 23. VUP Medical
• 24. W. L. Gore & Associates, Inc.
• 25. Xeltis B.V.